Ilan Oren
Board Member
Neurology
Axovant Sciences
Switzerland
Biography
Mr. Ilan Oren has served as a member of the Board of Axovant Sciences since March 2015. Mr. Oren has served as Vice President, Business Development at Dexcel Pharma Technologies Ltd., an international pharmaceutical company involved in the development, manufacture and commercialization of pharmaceuticals, since September 2011. From 2007 to July 2011, he was employed by L.E.K. Consulting and advised clients in the life sciences sector on corporate strategy, mergers and acquisitions, licensing and drug commercialization projects. Mr. Oren currently serves as a director of Cynapsus Therapeutics Inc., a publicly traded specialty pharmaceutical company, and as a director of Roivant Sciences Ltd. Mr. Oren received his B.A. in Economics from Harvard College. We believe that his extensive leadership experience and knowledge of the life sciences industry qualifies him to serve on the Board.
Research Interest
Pharmaceuticals, drugs,life sciences, therapeutics.
